- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: blue®m Gel
Total 406 results
-
AllerganCompleted
-
Abbott Medical DevicesTerminatedCoronary Artery DiseaseNetherlands, Australia, Singapore, China
-
Genome & CompanyMerck Sharp & Dohme LLCRecruitingBiliary Tract CancerKorea, Republic of
-
Mohit KheraTerminatedErectile Dysfunction | HypogonadismUnited States
-
Universidade Federal de Santa MariaFranciscan University CenterCompleted
-
Almirall, S.A.RecruitingKeratosis, ActinicPoland, Spain, United Kingdom, France, Germany, Italy
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedMyelodysplastic Syndrome | Aplastic AnemiaUnited States
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHepatitis CUnited States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Puerto Rico
-
University of California, San FranciscoRecruiting
-
Cairo UniversityUnknownPenile Prosthesis; ComplicationsEgypt
-
Gilead SciencesCompleted
-
Taro Pharmaceuticals USACompleted
-
Sensifree Ltd.CompletedBlood Pressure MeasurementUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoThrasher Research FundUnknownWest SyndromeUnited States
-
Brigham and Women's HospitalBeth Israel Deaconess Medical CenterCompletedObstructive Sleep ApneaUnited States
-
Washington University School of MedicineBioMarin PharmaceuticalWithdrawnNon-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Solid Tumors | Carcinoma, Non-Small Cell Lung | Non-Small-Cell Lung Carcinoma
-
Gilead SciencesCompletedChronic Hepatitis CIsrael, United Kingdom, Australia, Spain, Canada, New Zealand
-
Parc de Salut MarCompleted
-
University of California, San FranciscoGilead SciencesCompletedHepatitis C, ChronicUnited States
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Belgium, Italy, United Kingdom
-
Gilead SciencesCompletedHepatitis C Virus InfectionIndia
-
Gilead SciencesCompleted
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States
-
University of ArkansasAmgenTerminatedMultiple MyelomaUnited States
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, New Zealand, Puerto Rico, Australia
-
Gilead SciencesCompleted
-
Luye Pharma Group Ltd.Completed
-
Atara BiotherapeuticsMerck Sharp & Dohme LLCTerminatedNasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Epstein-Barr Virus Infections | Epstein-Barr Viraemia | Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)United States
-
Gilead SciencesCompletedHepatitis C Virus InfectionSingapore, Vietnam, China, Thailand, Malaysia
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France
-
Gilead SciencesCompletedHepatitis C Virus InfectionSpain, Switzerland, United Kingdom
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Italy, Spain, United Kingdom, Austria
-
Coordinación de Investigación en Salud, MexicoCompletedObesity | Insulin ResistanceMexico
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France, Canada, Germany, Puerto Rico, United Kingdom, Belgium, Italy, China
-
AbbVieIQVIA, formerly QuintilesCompletedAdvanced Parkinson's DiseaseUnited Kingdom, Czechia, United States, Australia, Canada, Israel, New Zealand, Poland, Portugal, Russian Federation, Thailand
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico, New Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionHong Kong, United States, France, Canada, Germany, United Kingdom, Belgium, Italy, Puerto Rico
-
Atara BiotherapeuticsNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedEBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV LymphomaUnited States
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Repurposed Therapeutics, Inc.CompletedMotion SicknessUnited States
-
University of VirginiaUnknownCentral Line-associated Bloodstream Infection (CLABSI) | Line Insertion SiteUnited States
-
AllerganWithdrawn
-
AbbVie (prior sponsor, Abbott)Quintiles, Inc.CompletedAdvanced Parkinson's DiseaseUnited States, Germany
-
St. Jude Children's Research HospitalBaylor College of Medicine; Gateway for Cancer ResearchActive, not recruitingAcute Lymphoblastic LeukemiaUnited States, Canada